Therapeutic efficacy of antitumor dendritic cell vaccinations correlates with persistent Th1 responses, high intratumor CD8+ T cell recruitment and low relative regulatory T cell infiltration Gregory DriessensLaurence GordowerCatherine Bruyns Original Article 28 March 2008 Pages: 1745 - 1756
Virulizin® induces production of IL-17E to enhance antitumor activity by recruitment of eosinophils into tumors Tania BenatarMing Y. CaoAiping H. Young Original Article 20 March 2008 Pages: 1757 - 1769
Immunization with a GM3 ganglioside nanoparticulated vaccine confers an effector CD8+ T cells-mediated protection against melanoma B16 challenge Zaima MazorraCirce MesaLuis E. Fernández Original Article 20 March 2008 Pages: 1771 - 1780
Targeting activity of a TCR/IL-2 fusion protein against established tumors Jinghai WenXiaoyun ZhuHing C. Wong Original Article 28 March 2008 Pages: 1781 - 1794
Selective accumulation of differentiated FOXP3+ CD4+ T cells in metastatic tumor lesions from melanoma patients compared to peripheral blood Camilla JandusGilles BioleyPedro Romero Original Article 15 April 2008 Pages: 1795 - 1805
Progression of intracranial glioma disrupts thymic homeostasis and induces T-cell apoptosis in vivo Abdeljabar El AndaloussiYu HanMaciej S. Lesniak Original Article 05 April 2008 Pages: 1807 - 1816
Assessment of immunologic response and recurrence patterns among patients with clinical recurrence after vaccination with a preventive HER2/neu peptide vaccine: from US Military Cancer Institute Clinical Trials Group Study I-01 and I-02 Asna AminLinda C. BenavidesGeorge E. Peoples Original Article 08 April 2008 Pages: 1817 - 1825
Therapeutic effect of a T helper cell supported CTL response induced by a survivin peptide vaccine against murine cerebral glioma Michael J. CiesielskiDanuta KozborRobert A. Fenstermaker Original Article 26 April 2008 Pages: 1827 - 1835
Differential responses of cellular immunity in patients undergoing neoadjuvant therapy followed by surgery for carcinoma of the oesophagus Marinke WesterterpMarja A. BoermeesterJ. Jan B. van Lanschot Original Article Open access 09 April 2008 Pages: 1837 - 1847
Immunomodulatory drugs Revlimid® (lenalidomide) and CC-4047 induce apoptosis of both hematological and solid tumor cells through NK cell activation Dan ZhuLaura G. CorralBernd Stein Original Article 08 April 2008 Pages: 1849 - 1859
Dendritic cell-based vaccines suppress metastatic liver tumor via activation of local innate and acquired immunity Shinjiro YamaguchiTomohide TatsumiNorio Hayashi Original Article 26 April 2008 Pages: 1861 - 1869
RhoC a new target for therapeutic vaccination against metastatic cancer Lynn WenandyRikke Bæk SørensenMads Hald Andersen Original Article Open access 16 April 2008 Pages: 1871 - 1878
Kinetics of anti-carcinoembryonic antigen antibody internalization: effects of affinity, bivalency, and stability Michael M. SchmidtGreg M. ThurberK. Dane Wittrup Original Article 12 April 2008 Pages: 1879 - 1890
Intratumoral immunocytokine treatment results in enhanced antitumor effects Erik E. JohnsonHillary D. LumPaul M. Sondel Original Article 26 April 2008 Pages: 1891 - 1902
HLA typing demands for peptide-based anti-cancer vaccine Dirk NagorsenEckhard Thiel Short Communication 04 March 2008 Pages: 1903 - 1910
